BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4552533)

  • 1. [Significance of infectious multiple resistance in pathogens causing pyelonephritis].
    Naumann G; Fanger K; Kunkel M
    Z Gesamte Inn Med; 1972 Jan; 27(1):18-21. PubMed ID: 4552533
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of chloramphenicol against different E. coli strains in vitro and in experimental pyelonephritis].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Arzneimittelforschung; 1968 Sep; 18(9):1123-7. PubMed ID: 4885372
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the bacterilogy and serology of experimental pyelonephritis under the action of chloramphenicol].
    Ritzerfeld W; Prát V; Konícková L; Losse H
    Arch Hyg Bakteriol; 1967 Oct; 151(5):529-37. PubMed ID: 4882586
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on chloramphenicol sensitivity of an E. coli strain in experimental pyelonephritis].
    Hatala M; Ritzerfeld W; Prat V; Konickova L; Losse H
    Arch Hyg Bakteriol; 1968 Apr; 152(2):181-6. PubMed ID: 4884481
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sensitivity of an Escherichia coli strain to chloramphenicol during therapy of experimental pyelonephritis].
    Hatala M; Ritzerfeld W; Prát V; Konícková L; Losse H
    Cas Lek Cesk; 1969 Sep; 108(39):1156-60. PubMed ID: 4897608
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug sensitivity of urinary microflora and the effect of treatment in exacerbated chronic pyelonephritis].
    Robeva R; Gruev I; Vasilev T; Neshev Kh
    Vutr Boles; 1986; 25(3):68-74. PubMed ID: 3765581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Occurrence of the R-factor in children. I. Incidence of transmissible resistance to antibiotics in Escherichia coli strains isolated from clinically healthy children and children with pyelonephritis].
    Lipková V; Seckárová A; Janousková J; Krcméry V; Hausmannová A; Bátorová L
    Cesk Epidemiol Mikrobiol Imunol; 1971 Jul; 20(4):169-74. PubMed ID: 4255283
    [No Abstract]   [Full Text] [Related]  

  • 8. [Microbial spectrum in chronic pyelonephritis and the drug sensitivity of the microorganisms].
    Gruev I; Lobutova M; Markova B; Neshev Kh; Robeva R
    Vutr Boles; 1985; 24(3):33-8. PubMed ID: 4024620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of chloramphenicol on experimental kidney infection caused by strains of E. coli with various sensitivity in vitro].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Cas Lek Cesk; 1969 Mar; 108(10):300-6. PubMed ID: 4887122
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of pyelonephritis in pregnancy.
    Hibbard L; Thrupp L; Summeril S; Smale M; Adams R
    Am J Obstet Gynecol; 1967 Jul; 98(5):609-15. PubMed ID: 5338897
    [No Abstract]   [Full Text] [Related]  

  • 11. [The antibiotic effectivity of doxycycline, tetracycline and chloramphenicol in the agar diffusion test].
    Müller J
    Med Klin; 1970 Oct; 65(42):1821-5. PubMed ID: 4933236
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current status of antibiotic resistance of pyelonephritis causing pathogens].
    Iarovoĭ SK; Maksimov VA; Shimanovskiĭ NL; Kareva EN
    Urologiia; 2010; (2):21-7. PubMed ID: 20967991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microbial spectrum and microbial resistance in ambulatory and stationary urological patients].
    Weissbach L; Tümmers H; Primavesi CA
    Z Urol Nephrol; 1970 Oct; 63(10):763-71. PubMed ID: 4994620
    [No Abstract]   [Full Text] [Related]  

  • 14. [Microbial flora sensitivity to antibacterial agents in chronic pyelonephritis patients who have had acute kidney failure].
    Shkrob OS; Sorokina MI; Navolotskaia TI; Isaev NM; Dobrovol'skii VI
    Antibiotiki; 1981 Mar; 26(3):140-2. PubMed ID: 7235659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microbiological characteristics of infectious processes in children with chronic obstructive pyelonephritis].
    Iatsyk PK; Sentsova TB; Gabibli RT
    Urol Nefrol (Mosk); 1988; (4):17-20. PubMed ID: 3064381
    [No Abstract]   [Full Text] [Related]  

  • 16. The diagnostic and epidemiologic significance of nephropathogenic Escherichia coli serotypes.
    Borowski J; Dzierzanowska D; Zaremba M
    Arch Immunol Ther Exp (Warsz); 1970; 18(3):32-45. PubMed ID: 4923031
    [No Abstract]   [Full Text] [Related]  

  • 17. Nalidixic acid in urinary tract infections with particular reference to the emergence of resistance.
    Cederberg A; Denneberg T; Ekberg M; Juhlin I
    Scand J Infect Dis; 1974; 6(3):259-64. PubMed ID: 4607842
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sensitivity of an E. coli strain during therapy of experimental pyelonephritis using nalidixic acid].
    Hatala M; Ritzerfeld W; Prát V; Konícková L; Losse H
    Cas Lek Cesk; 1970 Mar; 109(14):291-6. PubMed ID: 4909024
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bacterial spectrum and pathogen resistance in chronic primary and secondary pyelonephritis].
    Hofmann W; Langkopf B
    Z Urol Nephrol; 1982 Aug; 75(8):579-85. PubMed ID: 6758412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microbiologic indices of the urine in patients with various courses of pyelonephritis].
    Rudenko AV; Maĭdannik VG; Pilipenko VN
    Vrach Delo; 1989 Aug; (8):50-2. PubMed ID: 2588529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.